combretastatin has been researched along with flavone acetic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaplin, DJ; Hill, SA; Parkins, CS; Pettit, GR | 1 |
| Gore, M; Gourley, C; Hall, M; Jayson, G; Kaye, S; Ledermann, J; McNeish, I; Perren, T; Rustin, G | 1 |
1 review(s) available for combretastatin and flavone acetic acid
| Article | Year |
|---|---|
Targeted anti-vascular therapies for ovarian cancer: current evidence.
Topics: Angiogenesis Inhibitors; Angiopoietins; Angiostatins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bibenzyls; Female; Fibroblast Growth Factors; Flavonoids; Humans; Molecular Targeted Therapy; Neovascularization, Pathologic; Ovarian Neoplasms; Thrombospondins; Treatment Outcome; Vascular Endothelial Growth Factors | 2013 |
1 other study(ies) available for combretastatin and flavone acetic acid
| Article | Year |
|---|---|
Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Depsipeptides; Flavonoids; Mice; Mice, Inbred CBA; Neoplasms, Experimental; Oligopeptides; Regional Blood Flow; Stilbenes; Tirapazamine; Triazines; Tubulin; Tumor Necrosis Factor-alpha; Vinblastine | 1996 |